Approval · Notice of Compliance 31326 · 2023
GALAFOLD: Notice of Compliance 31326
Issued July 28, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31326
- Date
- July 28, 2023
- Company
- Amicus Therapeutics Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GALAFOLD | 02468042 | Marketed |
Medicinal ingredients
- MIGALASTAT HYDROCHLORIDE 123 MG per CAP